Artificial intelligence (AI) is revolutionising healthcare services
24 February 2021
- AI may improve clinical research through its ability to better translate RWD into RWE, thus providing more valid evidence of clinical benefits and risks.
- AI is poised to transform the drug and device development process, helping researchers refine the approval process and significantly cutting both the time and the expense needed to bring products to market.
Click here to learn more about SEDGE AI.
Click here to learn about how AI can enhance RWE analysis.
About SVMPharma
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.
For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com
ref: FEB2021VN001